Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01894217 · ClinicalTrials.gov registry record · Phase 1
Statin Therapy to Improve Medication Adherence
A Phase 1 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 1
- Development phase
- 63
- Enrollment target
NCT01894217 is a Phase 1 study that has completed, run by Duke University. The registered enrollment target is 63 participants.
The verdict
NCT01894217, a Phase 1 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to examine if using genetics can improve statin adherence in patients who should be taking statins but are not because of prior side effects with statins. This study will assist physicians in making a personalized health care plan for prevention of cardiovascular disease.
Interventions
- GENETIC Genetic testing and reporting for SLCO1B1*5 allele
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01894217
The ClinicalTrials.gov registry entry for NCT01894217 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genetic testing and reporting for SLCO1B1*5 allele is the first listed.
NCT01894217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01894217 about?
NCT01894217 is a clinical study titled "Statin Therapy to Improve Medication Adherence". The purpose of this pilot study is to examine if using genetics can improve statin adherence in patients who should be taking statins but are not because of prior side effects with statins. This study will assist physicians in making a personalized health care plan for prevention of cardiovascular d...
What is the current status of trial NCT01894217?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 63 participants. The study started on 2011-05. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01894217?
The interventions under investigation include: Genetic testing and reporting for SLCO1B1*5 allele (GENETIC).
Who is sponsoring clinical trial NCT01894217?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.